Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Syngenta Crop Participation AG has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution landscape for this entity is restricted to 1 distinct examiner and 1 distinct art unit. This suggests that the current patenting activity is concentrated on a single technological application or a specific set of claims within the biological sciences. The involvement of only a single distinct art unit indicates that the company's current filings do not span multiple examination specialties at the patent office, which may reflect a very specific research focus for this particular portfolio.
The busiest examiner, SAEED, ALI S, is responsible for 1 busiest examiner pending action. With only a single distinct examiner and art unit involved, the prosecution process is streamlined through this individual. The outcome of the 1 pending office action will provide the primary indicator for the company's current success in this technology sector. Because SAEED, ALI S is the only examiner listed, the company's immediate intellectual property goals are dependent on the resolution of the pending office action currently under review. This concentration of activity requires a targeted legal strategy focused on the specific requirements of the assigned examiner to ensure a favorable result.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16468592 | ADJUVANTS | SAEED, ALI S | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16468592 | ADJUVANTS | SAEED, ALI S | 1616 | §103 | Non-Final OA | — | Pending | Jun 11, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSyngenta Crop Participation AG has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ali S Saeed has the most, with 1 of Syngenta Crop Participation AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
